Express Healthcare

PlanMyMedicalTrip.com raises Rs 1.25 crore from angel investors

101

Aims to strengthen presence, boost the digital experience and venture into newer geographies with the raised capital

PlanMyMedicalTrip.com, a platform that offers international patients access to medical care at competitive prices, recently raised Rs 1.25 crore funding from three angel investors – Bhanu Vikram Parsotam, Rohan Desai and Paras Patel. The funding was led by Founder and company CEO, Anurav Rane. The venture intends on utilising the fresh capital to increase its catalyst network across the world and improving their customer’s digital experience. These apart, the portal also plans on expanding its reach to countries that are rich with prospects for medical tourism such as Thailand, UAE, Brazil and Germany.

The funding goes on to prove that the field of medical tourism holds much promise. PlanMyMedicalTrip.com, in specific, connects healthcare providers and medical tourists by using an e-commerce platform. The company acts as a one-stop destination for patients to compare doctors and hospitals, read reviews, receive end-to-end guidance on the treatment, travel and stay and be rest assured of quality.

Talking about this new development, PlanMyMedicalTrip.com Founder and CEO, Anurav Rane said, “Even though our team strictly adheres to the company’s growth strategy to achieve its goals, this funding will help us serve our customers even better. It will also assist us in keeping our energies focused on our philosophy of ‘Humanity is the only religion’.”

Highlighting the reason for investing in PlanMyMedicalTrip.com, Bhanu Vikram Parsotam said, “I have been a part of the healthcare sector in the USA for close to two decades now. So, I am familiar with patient requirements here and strongly believe that PlanMyMedicalTrip.com is doing the right thing at the right time. Together with the PlanMyMedicalTrip.com representatives, I’m positive that we will be able to boost healthcare facilities across the globe.”

- Advertisement -

Comments are closed.